Love Employee/iStock via Getty Images Investment Overview - Explaining Perspective's Stock Surge In 2026 Perspective Therapeutics ( CATX ) is a radiopharmaceuticals specialist that went public in February 2023, via the merger of Nasdaq listed Isoray Inc., and privately held Viewpoint Molecular Targeting. In early 2021 and mid-2024 Perspective stock achieved short-lived share price highs of >$15 pe...
Love Employee/iStock via Getty Images Investment Overview - Explaining Perspective's Stock Surge In 2026 Perspective Therapeutics ( CATX ) is a radiopharmaceuticals specialist that went public in February 2023, via the merger of Nasdaq listed Isoray Inc., and privately held Viewpoint Molecular Targeting. In early 2021 and mid-2024 Perspective stock achieved short-lived share price highs of >$15 per share, but a couple of underwhelming data readouts - most notably from a Phase 1/2a clinical trial of its candidate VMT-α-NET, in patients with unresectable or metastatic SSTR2-positive neuroendocrine tumors ("NETs") - dropped the share price back to ~$3. In January this year, however, stock began to climb rapidly in value, rising from ~$2.5 per share, to >$4 per share, likely due to news that French Pharma giant Sanofi ( SNY ) had opted to discontinue its SSTR2-targeted radioimmunotherapy agent, Alphamedix, which it had suggested only months before it planned to enter into a Phase 3 clinical study in gastroenteropancreatic neuroendocrine tumours (GEP-NETs). pipeline and catalysts upcoming (presentation) As we can see above (source: Perspective investor presentation ), Perspective continues to develop its SSTR2 candidate targeting NETs, as well as a melanoma and a solid tumor candidate. CEO Johan Spoor presented at the JP Morgan Healthcare conference last month, calling radiopharmaceuticals the "third pillar" of cancer treatment, alongside chemotherapy and immuno-oncology. The CEO explained: If something shows up on a tumor cell, but nowhere else, then we can target it. If we can target it, we can then cause a lot of damage there. And the great thing is it's a validated modality. It's becoming a mainstay. There's growth in the business. What we do is actually having a platform approach to this. These technologies link together. We use a proprietary chemical chelator that actually has been designed for superiority in biodistribution. And so we optimize our medicines to hav...
Gold was little changed as traders weighed the latest efforts by the US and Iran to find a negotiated solution to the two-month war that’s choked energy supplies and heightened inflation risks. Bullion was near $4,690 an ounce in early trading, having slipped 0.6% on Monday. US President Donald Trump convened a meeting of national security officials to discuss Iran’s latest peace proposal but main...
Gold was little changed as traders weighed the latest efforts by the US and Iran to find a negotiated solution to the two-month war that’s choked energy supplies and heightened inflation risks. Bullion was near $4,690 an ounce in early trading, having slipped 0.6% on Monday. US President Donald Trump convened a meeting of national security officials to discuss Iran’s latest peace proposal but maintained red lines on any deal to end the eight-week war, White House Press Secretary Karoline Leavitt said. Read More: Trump Discusses Iran Proposal With Aides, White House Says The comments followed reports that Tehran proposed an interim deal whereby it reopens the Strait of Hormuz in exchange for Washington ending its blockade of ships moving to and from Iranian ports. The energy-supply shock caused by the eight-week conflict has added to inflation risks, raising the likelihood that central banks will keep interest rates steady for longer or even hike them, which is a headwind for non-yielding bullion. Gold has lost about 11% since the conflict began at the end of February. Spot gold was up 0.2% at $4,690.55 an ounce at 6:14 a.m. in Singapore. Silver rose 0.5% to $75.88 an ounce. Platinum and palladium advanced. The Bloomberg Dollar Spot Index , a gauge of the US currency, dipped 0.1% on Monday.
Microsoft and OpenAI on Monday announced a sweeping overhaul of the partnership that has defined the commercial AI era, dismantling key pillars of exclusivity and revenue-sharing that bound the two companies together for years and replacing them with a looser, time-limited arrangement that gives both sides far more freedom to pursue rival relationships. The amended agreement, disclosed simultaneou...
Microsoft and OpenAI on Monday announced a sweeping overhaul of the partnership that has defined the commercial AI era, dismantling key pillars of exclusivity and revenue-sharing that bound the two companies together for years and replacing them with a looser, time-limited arrangement that gives both sides far more freedom to pursue rival relationships. The amended agreement, disclosed simultaneously in blog posts from both companies , marks the most significant restructuring since Microsoft first invested $1 billion in OpenAI in 2019 — and it transforms what was once the most consequential exclusive technology alliance in a generation into something that more closely resembles a strategic but arm's-length commercial relationship. Under the new terms, Microsoft will no longer pay any revenue share to OpenAI when customers access OpenAI models through Azure. OpenAI, meanwhile, will continue paying a revenue share to Microsoft through 2030 — at the same 20 percent rate — but that obligation is now subject to a total cap . Microsoft retains a license to OpenAI's intellectual property for models and products through 2032, but that license is now explicitly non-exclusive. And OpenAI, critically, can now serve all of its products to customers on any cloud provider — including Amazon Web Services and Google Cloud — ending the exclusivity that had been a cornerstone of the original deal. "The rapid pace of innovation requires us to continue to evolve our partnership to benefit our customers and both companies," Microsoft wrote in its blog post Monday. OpenAI echoed the framing, calling the amended agreement a move "grounded in flexibility, certainty, and a focus on delivering the benefits of AI broadly." The diplomatic language belies the drama that led to this moment — months of behind-the-scenes tension, competing deal announcements, public contradictions, and even the specter of litigation between two companies whose fates have been intertwined since the earliest days of...
Beyond Meat (NASDAQ: BYND) stock closed out Monday's trading solidly in the green. The plant-based food and beverage company's share price was up 4.1% at the end of the session and had been up as much as 10.3% earlier in trading. With the S&P 500 rising 0.1% and the N asdaq Composite rising 0.2% in Monday's daily trading session, Beyond stock had the benefit of a relatively tranquil market backdro...
Beyond Meat (NASDAQ: BYND) stock closed out Monday's trading solidly in the green. The plant-based food and beverage company's share price was up 4.1% at the end of the session and had been up as much as 10.3% earlier in trading. With the S&P 500 rising 0.1% and the N asdaq Composite rising 0.2% in Monday's daily trading session, Beyond stock had the benefit of a relatively tranquil market backdrop. Some meme stocks have recently seen resurgent market momentum, and Beyond has also seen increased bullish sentiment connected to new product launches. Image source: Getty Images. Continue reading
Elen11/iStock via Getty Images The U.S. Army will move ahead with a $591M General Dynamics ( GD ) contract to start production at an artillery and ammunition factory in Texas after severe delays prompted a review of whether the project should be canceled, Bloomberg reported Monday. A work stoppage order on the factory was lifted after eight months—it is not clear why the pause went into effect or ...
Elen11/iStock via Getty Images The U.S. Army will move ahead with a $591M General Dynamics ( GD ) contract to start production at an artillery and ammunition factory in Texas after severe delays prompted a review of whether the project should be canceled, Bloomberg reported Monday. A work stoppage order on the factory was lifted after eight months—it is not clear why the pause went into effect or why it was lifted—and the Army said it is now working on "the way forward" with General Dynamics ( GD ). The plant, which opened in May 2024 and was meant to have three lines making 30K 155 mm artillery shells per month, has not yet started production, after an Army letter to General Dynamics ( GD ) in June 2025 said the equipment at the site failed to meet the "technical requirements of the contract," according to reports at the time. Asked why work was ordered halted at the plant, the Army cited "performance concerns, risk allocation, and the need for contract modifications" in a statement to Bloomberg. General Dynamics ( GD ) reports Q1 earnings this week and may offer more detail on the future of the plant and capital spending it plans to make to improve the production process, Bloomberg reported. More on General Dynamics General Dynamics: Poised To Benefit From High Volume Of Government Contracts General Dynamics: Inexpensive Defense Leader General Dynamics Looks Undervalued As Submarines And Business Jets Ramp
"Let's Get Ruthless": Bulwark's Bill Kristol Suggests Illiberal Means Are Needed To Save Liberal Democracy Authored by Jonathan Turley, “Let’s get ruthless.” Those words are, unfortunately, nothing new in this age of rage . In just the last few weeks, various liberal pundits and politicians have been calling for radical and even violent action. Even comedian Margaret Cho publicly declared this wee...
"Let's Get Ruthless": Bulwark's Bill Kristol Suggests Illiberal Means Are Needed To Save Liberal Democracy Authored by Jonathan Turley, “Let’s get ruthless.” Those words are, unfortunately, nothing new in this age of rage . In just the last few weeks, various liberal pundits and politicians have been calling for radical and even violent action. Even comedian Margaret Cho publicly declared this week that “we need a feral, bloodthirsty, violent Democrat.” However, these words were reposted by Bill Kristol, the founder of the Weekly Standard and the current editor-in-chief of The Bulwark . Kristol was a leading conservative figure in the Republican Party. Kristol left the Republican Party and is now a vehemently anti-Trump writer. There are certainly good-faith reasons why some conservatives have broken with Trump on a variety of issues. However, the original column was endorsing the Democratic plan to pack the Supreme Court with an instant liberal majority to force through a slew of political changes in the country. Various Democrats have been pledging to not only impeach Trump (and a long list of other figures), but to pack the Supreme Court as soon as they regain power. James Carville declared, “If the Democrats win the presidency and both houses of Congress, I think on day one, they should expand the Supreme Court to 13. F— it. Eat our dust. Don’t run on it. Don’t talk about it. Just do it.” This Nike School of Constitutional Law is catching on with a wide array of pundits and professors. Just do it. Years ago , Harvard professor Michael Klarman laid out a radical agenda to change the system to guarantee Republicans “will never win another election.” However, he warned that “the Supreme Court could strike down everything I just described.” Therefore, the court must be packed in advance to allow these changes to occur. Former Obama Attorney General Eric Holder has put packing the Supreme Court front and center, explaining, “[We’re] talking about the acquisition and ...
Verizon Communications (NYSE:VZ) executives pointed to improving customer retention, lower acquisition costs, and a shift toward “healthier” growth as key drivers of first-quarter 2026 results, while also raising guidance for adjusted earnings per share growth and tightening expectations for postpai
Verizon Communications (NYSE:VZ) executives pointed to improving customer retention, lower acquisition costs, and a shift toward “healthier” growth as key drivers of first-quarter 2026 results, while also raising guidance for adjusted earnings per share growth and tightening expectations for postpai
Rambus (NASDAQ:RMBS) outlined its second-quarter outlook and provided updates on product transitions, supply chain conditions, and longer-term platform-driven opportunities during its latest earnings call. Guidance calls for sequential revenue growth in Q2 Management guided to second-quarter revenu
Rambus (NASDAQ:RMBS) outlined its second-quarter outlook and provided updates on product transitions, supply chain conditions, and longer-term platform-driven opportunities during its latest earnings call. Guidance calls for sequential revenue growth in Q2 Management guided to second-quarter revenu
Nvidia (NASDAQ: NVDA) has been one of the most successful companies in recent memory. It pivoted from gaming to focus on the potential implications of artificial intelligence (AI) -- long before the technology went viral. Nvidia's graphics processing units (GPUs) cornered the data center GPU market by providing the computational horsepower needed to underpin these next-generation algorithms. Conce...
Nvidia (NASDAQ: NVDA) has been one of the most successful companies in recent memory. It pivoted from gaming to focus on the potential implications of artificial intelligence (AI) -- long before the technology went viral. Nvidia's graphics processing units (GPUs) cornered the data center GPU market by providing the computational horsepower needed to underpin these next-generation algorithms. Concerns about a potential AI "bubble," slowing adoption of the technology, and increasing competition had driven Nvidia down by as much as 20%. However, a recent rebound in investor sentiment has sent the stock to a new record high. When the market closed on Monday, Nvidia's market cap climbed to $5.2 trillion. This leaves investors asking the quintessential investing question: Is it too late to buy Nvidia stock? Let's see what the evidence suggests. Continue reading
Brown & Brown (BRO) delivered earnings and revenue surprises of +2.06% and +1.44%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Brown & Brown (BRO) delivered earnings and revenue surprises of +2.06% and +1.44%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Critical Metals (NASDAQ:CRML), an explorer and developer of critical minerals for advanced technologies, closed Monday at $14.45, up 25.54%. The stock moved higher after news that it agreed to acquire European Lithium in an $835 million share deal. Investors are watching how the
Critical Metals (NASDAQ:CRML), an explorer and developer of critical minerals for advanced technologies, closed Monday at $14.45, up 25.54%. The stock moved higher after news that it agreed to acquire European Lithium in an $835 million share deal. Investors are watching how the
Greaves triumphs at Players Championship ‘I never thought I’d win one of these. Never’ Beau Greaves has made darts history by becoming the first woman to win a PDC ranking title. The 22-year-old beat three former world champions at the Players Championship in Milton Keynes, seeing off Rob Cross, Gary Anderson and Michael Smith. Greaves completed a nailbiting 8-7 victory over Smith in the final wit...
Greaves triumphs at Players Championship ‘I never thought I’d win one of these. Never’ Beau Greaves has made darts history by becoming the first woman to win a PDC ranking title. The 22-year-old beat three former world champions at the Players Championship in Milton Keynes, seeing off Rob Cross, Gary Anderson and Michael Smith. Greaves completed a nailbiting 8-7 victory over Smith in the final with a stunning 142 checkout. She said: “I can’t believe it. I was up a fair few legs and I started to think about it. It caught up with me. Continue reading...